Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 8	$ 139
Accounts receivable - trade (less allowance for doubtful accounts)	434	415
Unbilled revenue	301	269
Miscellaneous accounts receivable	85	65
Inventories	592	521
Current regulatory assets	319	109
Other current assets	229	135
Total current assets	1,968	1,653
Property, Plant, and Equipment, Net	29,261	26,807
Investments and Other Assets:
Nuclear decommissioning trust fund	1,159	982
Goodwill	411	411
Regulatory assets	1,289	1,100
Pension and other postretirement benefits	756	288
Other assets	891	789
Total investments and other assets	4,506	3,570
TOTAL ASSETS	35,735	32,030
Current Liabilities:
Current maturities of long-term debt	505	8
Short-term debt	545	490
Accounts and wages payable	1,095	958
Interest accrued	123	114
Current regulatory liabilities	113	121
Other current liabilities	445	489
Total current liabilities	2,826	2,180
Long-term Debt, Net	12,562	11,078
Deferred Credits and Other Liabilities:
Accumulated deferred income taxes and investment tax credits, net	3,499	3,211
Regulatory liabilities	5,848	5,282
Asset retirement obligations	757	696
Other deferred credits and liabilities	414	503
Total deferred credits and other liabilities	10,518	9,692
Commitments and Contingencies (Notes 2, 9, and 14)
Shareholders' Equity:
Common stock	3	3
Other paid-in capital, principally premium on common stock	6,502	6,179
Retained earnings	3,182	2,757
Accumulated other comprehensive income (loss)	13	(1)
Total shareholders' equity	9,700	8,938
Noncontrolling Interests	129	142
Total equity	9,829	9,080
TOTAL LIABILITIES AND EQUITY	$ 35,735	$ 32,030